Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Shares Outstanding (Weighted Average) (2016 - 2025)

STRATA Skin Sciences' Shares Outstanding (Weighted Average) history spans 14 years, with the latest figure at $4.5 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 21.61% year-over-year to $4.5 million; the TTM value through Sep 2025 reached $4.5 million, up 21.61%, while the annual FY2024 figure was $3.8 million, 9.03% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $4.5 million at STRATA Skin Sciences, up from $4.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $34.9 million in Q1 2023 and bottomed at $3.5 million in Q2 2023.
  • The 5-year median for Shares Outstanding (Weighted Average) is $4.5 million (2025), against an average of $18.3 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) soared 9252691.85% in 2021 before it tumbled 89.96% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $34.1 million in 2021, then grew by 1.94% to $34.7 million in 2022, then tumbled by 89.94% to $3.5 million in 2023, then rose by 9.03% to $3.8 million in 2024, then rose by 17.71% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Shares Outstanding (Weighted Average) are $4.5 million (Q3 2025), $4.2 million (Q2 2025), and $4.2 million (Q1 2025).